✦ LIBER ✦
665 A PHASE I/II STUDY OF FORETINIB, AN ORAL MULTIKINASE INHIBITOR TARGETING MET, RON, AXL, TIE-2 AND VEGFR IN ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
✍ Scribed by T. Yau; C.-J. Yen; P.-J. Chen; Y. Chau; R. Lencioni; H. Kallender; L.H. Ottesen; R.T.-P. Poon
- Book ID
- 117379810
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 39 KB
- Volume
- 54
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.